The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
Dabrafenib and trametinib in BRAFV600E mutated glioma
Brown, N. F., Carter, T. J., Kitchen, N. D., & Mulholland, P. J. (2017) · CNS Oncology · doi:10.2217/cns-2017-0006 · Cited by 67
Jiang, H., Cui, Y., Wang, J., & Lin, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13555 · Cited by 66
Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
Chamberlain, M. C., & Johnston, S. K. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9722-2 · Cited by 62
Sun, P., Kohrman, M. H., Liu, J., Guo, A., Rogerio, J. W., & Krueger, D. A. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.658907 · Cited by 61
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Panageas, K. S., IWAMOTO, F. M., Cloughesy, T. F., Aldape, K., Rivera, A. L., Eichler, A. F., Louis, D. N., Paleologos, N. A., Fisher, B. J., Ashby, L., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos065 · Cited by 57
Self-citationRepeat surgery for recurrent low-grade gliomas should be standard of care
Uppstrom, T. J., Singh, R., Hadjigeorgiou, G. F., Magge, R., & Ramakrishna, R. R. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.09.013 · Cited by 54
Coburger, J., & Wirtz, C. R. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03052-4 · Cited by 54
Weller, J. M., Tzaridis, T., Mack, F., Steinbach, J. P., Schlegel, U. S., Hau, P., Krex, D., Grauer, O. M., Goldbrunner, R., Bähr, O., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30502-9 · Cited by 54
Mohammadi, A. M., Sullivan, T. B., Barnett, G. H., Recinos, V. R., Angelov, L., Kamian, K., & Vogelbaum, M. A. (2013) · Neurosurgery · doi:10.1227/neu.0000000000000278 · Cited by 51
Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients
Neumann, J. E., Dorostkar, M. M., Korshunov, A., Mawrin, C., Koch, A., Giese, A., & Schüller, U. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw015 · Cited by 46
Gallo, P., Cecchi, P. C., Locatelli, F., Boscolo‐Rizzo, P., Ghimenton, C., Gerosa, M. A., & Pinna, G. (2013) · British Journal of Neurosurgery · doi:10.3109/02688697.2013.776666 · Cited by 45
Marks, A. M., Bindra, R. S., DiLuna, M. L., et al. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.26969 · Cited by 45
Wahl, M. T., Chang, S. M., Phillips, J. J., Molinaro, A. M., Costello, J., Mazor, T., Alexandrescu, S., Lupo, J., Nelson, S. J., Berger, M. S., et al. (2017) · Cancer · doi:10.1002/cncr.30909 · Cited by 44
Self-citationChen, L., Shen, C. J., Redmond, K. J., Page, B. R., Kummerlowe, M. N., McNutt, T., Bettegowda, C., Rigamonti, D., Lim, M. K., & Kleinberg, L. R. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.031 · Cited by 41
Churilla, T. M., Handorf, E. R., Collette, S., Collette, L., Dong, Y., Aizer, A. A., Köcher, M., Soffietti, R., Alexander, B. M., & Weiss, S. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx332 · Cited by 41
Self-citationLo, S. S.-M., Cho, K. H., Hall, W. A., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.10359 · Cited by 40
Tang, S., Liao, J., & Long, Y. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.02.004 · Cited by 40
Yang, K., Nath, S., Koziarz, A., Badhiwala, J. H., Ghayur, H., Sourour, M., Catana, D., Nassiri, F., Alotaibi, M. B., Kameda-Smith, M. M., et al. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.163 · Cited by 38
Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)
Ebrahimi‐Fakhari, D., & Franz, D. N. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1751124 · Cited by 34
Acharya, S., Robinson, C. G., Michalski, J. M., Mullen, D. F., DeWees, T. A., Campian, J. L., Chundury, A., Bottani, B., Hallahan, D. E., Bradley, J. D., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.099 · Cited by 33
Self-citationAlternating Electric Fields for the Treatment of Glioblastoma
Sampson, J. H. (2015) · JAMA · doi:10.1001/jama.2015.16701 · Cited by 29
van den Bent, M. J., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Sanson, M., Brandes, A. A., Wick, W., Clément, P. M., Baurain, J., Mason, W., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz126.006 · Cited by 29
Gandhi, L., Ou, S. I., Shaw, A. T., Barlési, F., Dingemans, A. C., Kim, D., Camidge, D. R., Hughes, B. G. M., Yang, J. C., de Castro, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.019 · Cited by 28
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study
Carvalho, B., Fernandes, A. C., Almeida, D. S., Sampaio, L., Costa, A., Caeiro, C., Osório, L., Castro, L., Linhares, P., Damasceno, M., et al. (2015) · Oncology Research and Treatment · doi:10.1159/000431236 · Cited by 26
Banfill, K., Bownes, P. J., Clair, S. E. S., Loughrey, C., & Hatfield, P. (2012) · British Journal of Neurosurgery · doi:10.3109/02688697.2012.690913 · Cited by 24
Yomo, S., & Hayashi, M. (2016) · BMC Cancer · doi:10.1186/s12885-016-2983-9 · Cited by 24
McGirt, M. J., & Brem, H. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1092-2 · Cited by 22
Self-citationHiguchi, Y., Yamamoto, M., Serizawa, T., Sato, Y., Shuto, T., Akabane, A., Jokura, H., Yomo, S., Nagano, O., Kawagishi, J., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03242-8 · Cited by 22
Wen, P. Y., Stein, A., van den Bent, M. J., Grève, J. D., Dietrich, S., Vos, F. D., von Bubnoff, N. C. C., van Linde, M., Lai, A., Prager, G. W., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz175.073 · Cited by 22
Self-citationBevacizumab for acute neurologic deterioration in patients with glioblastoma
Kaley, T. J., Nolan, C. P., Carver, A. C., & Omuro, A. M. P. (2013) · CNS Oncology · doi:10.2217/cns.13.40 · Cited by 19
Self-citationThe Burden of Subependymal Giant Cell Astrocytomas Associated With Tuberous Sclerosis Complex
Skalicky, A. M., Rentz, A. M., Liu, Z., Wheless, J. W., Pelletier, C. L., Dunn, D. W., Frost, M., Nakagawa, J., Magestro, M., Prestifilippo, J., et al. (2014) · Journal of Child Neurology · doi:10.1177/0883073814523318 · Cited by 18
Raman, S., Mou, B., Hsu, F., Valev, B., Cheung, A., Vallières, I., Ma, R., McKenzie, M. R., Beaton, L., Rackley, T., et al. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.02.001 · Cited by 12
Lo, S. S.-M., Hall, W. A., Cho, K. H., et al. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00181-3 · Cited by 10
Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion
Epari, S., Pai, T., Desai, S. B., Wadile, A. D., Gupta, T., Goda, J. S., Moiyadi, A. V., Shetty, P. M., KANE, S. V., & Jalali, R. (2017) · Neurology India · doi:10.4103/0028-3886.198195 · Cited by 10
Treatment for Patients With Newly Diagnosed Glioblastoma
Chamberlain, M. C. (2016) · JAMA · doi:10.1001/jama.2016.1844 · Cited by 2
Berger (1994) · doi:10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d
Cited by
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
Gritsch, S., Batchelor, T. T., & Gonzalez Castro, L. N. (2022) · Cancer · doi:10.1002/cncr.33918 · Cited by 372
Berger, T. R., Wen, P. Y., Lang-Orsini, M., & Chukwueke, U. N. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2844 · Cited by 297
Self-citationPouyan, A., Ghorbanlo, M., Eslami, M., Jahanshahi, M., Ziaei, E., Salami, A., Mokhtari, K., Shahpasand, K., Farahani, N., Meybodi, T. E., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02267-0 · Cited by 271
Shi, W., Blumenthal, D. T., Oberheim Bush, N. A., Kebir, S., Lukas, R. V., Muragaki, Y., Zhu, J.-J., & Glas, M. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03540-6 · Cited by 61
Metadata
- Authors
- Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., Forsyth, P., Hattangadi-Gluth, J., Holdhoff, M., Horbinski, C., Junck, L., Kaley, T., Kumthekar, P., Loeffler, J. S., Mrugala, M. M., Nagpal, S., Pandey, M., Parney, I., Peters, K., Puduvalli, V. K., Robins, I., Rockhill, J., Rusthoven, C., Shonka, N., Shrieve, D. C., Swinnen, L. J., Weiss, S., Wen, P. Y., Willmarth, N. E., Bergman, M. A., & Darlow, S. D.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2020-11
- Volume
- 18
- Issue
- 11
- Pages
- 1537-1570
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3097339274
- Cited by
- 539
- References
- 236
- FWCI
- 36.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.